Test Bank For Clayton's Basic Pharmacology for Nurses 19th Edition By Bruce Clayton, Michelle Willihnganz, Samuel Gurevitz ( ) / 9780323796309 / Chapter 1-48 / Complete Questions and Answers A+

Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition
qy qy qy qy qy qy qy qy qy q
y




By Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton Com
qy qy qy qy qy qy qy qy qy




plete

,Chapter 01: Drug Definitions, Standards, and Information Sources Willihnga
qy qy qy qy qy qy qy qy


nz: Clayton’s Basic Pharmacology for Nurses, 19th Edition
qy qy qy qy qy qy qy




MULTIPLE CHOICE qy




1. Which name dentifies a drug listed by the US Food a
qy qqy qy qy qy qy qy qy qy qy


ndDrug Administration (FDA)?
y
q qy qy


a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: C qy


The official name s the name under which a drug s liste
qy qy qqy qy q y qy qy qy qy qqy qy


d by the FDA. The brand name, or trademark, s the name
qy qy qy qy qy qy qy qy qqy qy qy q


ygiven to a drug by ts manufacturer. The nonproprietary, o
qy qy qy qy qqy qy qy qy qy


r generic, name s provided by the United States Adopted
qy qy qqy qy qy qy qy qy qy qy


Names Council. qy




DIF: Cognitive Level: Knowledge REF: p. 9 qy qy qy qy


OBJ: 1NAT: NCLEX Client Needs Category: Safe, Effective C
qy qy qy qy qy qy qy qy


areEnvironment TOP: Nursing Process Step: Assessment
y
q qy q y qy qy qy


CON: qy


Patient Education qy




2. Which source contains information specific to nutritional supplements?
qy qy qy qy qy qy qy


a. USP Dictionary of USAN &International Drug Names
qy qy qy qy qy qy qy


b. Natural Medicines Comprehensive Database qy qy qy


c. United States Pharmacopoeia/National Formulary (USP NF)
qy qy qy qy qy


d. Drug Interaction Facts qy qy




ANS: C qy


United States Pharmacopoeia/National Formulary contains information specific to nutritiona
qy qy qy qy qy qy qy qy


lsupplements. USP Dictionary of USAN & International Drug Names is a compilation of d
y
q qy qy qy qy qy qy qy qy qy qy qy qy qy


rugnames, pronunciation guide, and possible future FDA approved drugs; it does not inclu
y
q qy qy qy qy qy qy qy qy qy qy qy qy


de nutritional supplements. Natural Medicines Comprehensive Database contains
qy qy qy qy qy qy qy


evidence-
based information on herbal medicines and herbal combination products; it does notinclude i
qy qy qy qy qy qy qy qy qy qy qy y
q qy


nformation specific to nutritional supplements. Drug Interaction Facts contains comprehen
qy qy qy qy qy qy qy qy qy


sive information on drug interaction facts; it does not include nutritional supplements.
qy qy qy qy qy qy qy qy qy qy qy




DIF: Cognitive Level: Knowledge REF: p. 4 qy qy q y qy


OBJ: 3NAT: NCLEX Client Needs Category: Physiological Int
qy qy qy qy qy qy qy qy


egrity
TOP: Nursing Process Step: Assessment CON: Nutrition | Patient Education
q y qy qy qy q y qy qy qy




3. Which drug reference contains drug monographs that describe all drugs in a therapeutic class?
qy qy qy qy qy qy qy qy qy qy qy qy qy


a. Drug Facts and Comparisons qy qy qy

,Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Editi
qy qy qy qy qy qy qy qy qy 3
on
b. Drug Interaction Facts qy qy


c. Handbook on Injectable Drugs qy qy qy


d. Martindale—The Complete Drug Reference qy qy qy




ANS: A qy


Drug Facts and Comparisons contains drug monographs that describe all drugs in
qy qy qy qy qy qy qy qy qy qy qy qy


atherapeutic class. Monographs are formatted as tables to allow comparison of simil
y
q qy qy qy qy qy qy qy qy qy qy qy


arproducts, brand names, manufacturers, cost indices, and available dosage forms
y
q qy qy qy qy qy qy qy qy qy qy


Online version is available.
qy qy qy




DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 qy qy q y qy qy qy


OBJ: 3 qyqyq y NAT: NCLEX Client Needs Category: Physiological Integrity q y qy qy qy qy qy


TOP: Nursing Process Step: Assessment CON: Safety | Patient Education | Clinical Judgment
q y qy qy qy q y qy qy qy qy qy qy




4. Which drug reference contains monographs about virtually every single-
qy qy qy qy qy qy qy qy


entity drug availablein the United States and describes therapeutic uses of drugs, includin
qy qy qy qy qy qy qy qy qy qy qy qy qy


g approved and unapproved uses?
qy qy qy qy


a. Martindale: The Complete Drug Reference qy qy qy qy


b. AHFS Drug Information qy qy


c. Drug Reference qy


d. Drug Facts and Comparisons qy qy qy




ANS: B qy


AHFS Drug Information contains monographs about virtually every single-
qy qy qy qy qy qy qy qy


entity drug available in the United States and describes therapeutic uses of drugs, including
qy qy qy qy qy qy qy qy qy qy qy qy qy qy


approved andunapproved uses. qy qy qy




DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 qy qy q y qy qy qy


OBJ: 3 qyqyq y NAT: NCLEX Client Needs Category: Physiological Integrity q y qy qy qy qy qy


TOP: Nursing Process Step: Planning
q y CON: Safety | Patient Education | Clinical Judgment
qy qy qy q y qy qy qy qy qy qy




5. Which online drug reference makes available to healthcare providers and the public a s
qy qy qy qy qy qy qy qy qy qy qy qy qy


tandard, comprehensive, up-to-date look up and downloadable resource about medicines?
qy qy qy qy qy qy qy qy qy


a. American Drug Index qy qy


b. American Hospital Formulary qy qy


c. DailyMed
d. Drug Reference qy




ANS: C qy


DailyMed makes available to healthcare providers and the public a standard, comprehensiv
qy qy qy qy qy qy qy qy qy qy qy


e,up-to-
y
q


date look up and downloadable resource about medicines. The American Drug Index isnot
qy qy qy qy qy qy qy qy qy qy qy qy y
q qy


appropriate for patient use. The American Hospital Formulary is not appropriate for patie
qy qy qy qy qy qy qy qy qy qy qy qy


nt use. The drug reference is not appropriate for patient use.
qy qy qy qy qy qy qy qy qy qy




DIF: Cognitive Level: Knowledge REF: p. 3 | p. 4 qy qy q y qy qy qy qy


OBJ: 3NAT: NCLEX Client Needs Category: Physiological Int
qy qy qy qy qy qy qy qy


egrity
TOP: Nursing Process Step: Implementation
qy qy qy qy


CON: Safety | Patient Education | Clinical Judgment
q y qy qy qy qy qy qy




6. Which legislation authorizes the FDA to determine the safety of a drug before its marketing?
qy qy qy qy qy qy qy qy qy qy qy qy qy qy


a. Federal Food, Drug, and Cosmetic Act (1938) qy qy qy qy qy qy


b. Durham Humphrey Amendment (1952) qy qy qy

, Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Editi
qy qy qy qy qy qy qy qy qy 4
on
c. Controlled Substances Act (1970) qy qy qy


d. Kefauver Harris Drug Amendment (1962) qy qy qy qy




ANS: A qy


The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the s
qy qy qy qy qy qy qy qy qy qy qy qy qy qy qy


afety of all drugs before marketing. Later amendments and acts helped tighten FDA contro
qy qy qy qy qy qy qy qy qy qy qy qy qy


l and ensure drug safety. The Durham Humphrey Amendment defines the kinds of drugs t
qy qy qy qy qy qy qy qy qy qy qy qy qy qy


hat cannot be used safely without medical supervision and restricts their sale to prescriptio
qy qy qy qy qy qy qy qy qy qy qy qy qy


n by a licensed practitioner. The Controlled Substances Act addresses only controlled subst
qy qy qy qy qy qy qy qy qy qy qy qy


ances andtheir categorization. The Kefauver Harris Drug Amendment ensures drug efficacy
qy qy qy qy qy qy qy qy qy qy qy q


and greaterdrug safety. Drug manufacturers are required to prove to the FDA the effective
y qy qy qy qy qy qy qy qy qy qy qy qy qy qy


ness of their products before marketing them.
qy qy qy qy qy qy




DIF: Cognitive Level: Knowledge REF: p. 5 Table l.3 qy qy qy qy qy qy


OBJ: 5 q y


NAT: NCLEX Client Needs Category: Physiological Integrit qy qy qy qy qy qy


yTOP: Nursing Process Step: Assessment
y
q qy qy qy qy


CON: Safety | Patient Education | Evidence | Health Care Law
q y qy qy qy qy qy qy qy qy qy




7. Which classification does meperidine (Demerol) fall under?
qy qy qy qy qy qy


a. I
b. II
c. III
d. IV
ANS: B qy


Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may lea
qy qy qy qy qy qy qy qy qy qy qy qy qy qy qy qy


d tosevere psychological and physical dependence. Schedule I drugs have high potential for
qy y
q qy qy qy qy qy qy qy qy qy qy qy qy


abuseand no recognized medical use. Schedule III drugs have some potential for abuse. Us
qy qy qy qy qy qy qy qy qy qy qy qy qy qy


e may lead to low to moderate physical dependence or high psychological dependence. Sc
qy qy qy qy qy qy qy qy qy qy qy qy qy


hedule IVdrugs have low potential for abuse. Use may lead to limited physical or psychol
qy qy qy qy qy qy qy qy qy qy qy qy qy qy qy


ogical dependence. qy




DIF: Cognitive Level: Knowledge REF: p. 10 qy qy q y qy


OBJ: 2NAT: NCLEX Client Needs Category: Safe, Effective C
qy qy qy qy qy qy qy qy qy


are Environment
qy


TOP: Nursing Process Step: Assessment CON: Patient Education | Addiction | Pain
q y qy qy qy q y qy qy qy qy qy




8. Which action would the FDA take to expedite drug development and approval for an outbre
qy qy qy qy qy qy qy qy qy qy qy qy qy qy


akof smallpox?
y
q qy


a. List smallpox as a health orphan disease.
qy qy qy qy qy qy


b. Omit the preclinical research phase. qy qy qy qy


c. Extend the clinical research phase. qy qy qy qy


d. Fast track the investigational drug.qy qy qy qy




ANS: D qy


Once the Investigational New Drug Application has been approved, the drug can receive h
qy qy qy qy qy qy qy qy qy qy qy qy qy


ighest priority within the agency, which is called fast tracking. A smallpox outbreak would
qy qy qy qy qy qy qy qy qy qy qy qy qy


become a priority concern in the world. Orphan diseases are not researched in a priority
qy qy qy qy qy qy qy qy qy qy qy qy qy qy qy qy


manner. Preclinical research is not omitted. Extending any phase of the research would me
qy qy qy qy qy qy qy qy qy qy qy qy qy


ana longer time to develop a vaccine. The FDA must ensure that all phases of the preclinical
y qy
q qy qy qy qy qy qy qy qy qy qy qy qy qy qy qy q


andclinical research phase have been completed in a safe manner.
y y
q qy qy qy qy qy qy qy qy qy




DIF: Cognitive Level: Knowledge qy qy REF: qyqyqy p. 7 qy OBJ: 5 qy